249 related articles for article (PubMed ID: 17644403)
21. [Management of testicular cancer].
Schneevoigt B; Stief CG; Karl A
MMW Fortschr Med; 2013 Dec; 155(21-22):40-2. PubMed ID: 24724271
[No Abstract] [Full Text] [Related]
22. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.
Kamran SC; Seisen T; Markt SC; Preston MA; Trinh QD; Frazier LA; Choueiri TK; Martin NE; Nguyen PL; Beard CJ
Eur Urol; 2018 Feb; 73(2):262-270. PubMed ID: 28687143
[TBL] [Abstract][Full Text] [Related]
23. NCCN clinical practice guidelines in oncology: testicular cancer.
Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
J Natl Compr Canc Netw; 2009 Jun; 7(6):672-93. PubMed ID: 19555582
[No Abstract] [Full Text] [Related]
24. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls.
Raghavan D; Boyer M
Prog Clin Biol Res; 1990; 350():309-18. PubMed ID: 2166960
[No Abstract] [Full Text] [Related]
25. [Systematic review 2007: Primary treatments of testicular germ cell tumors after radical orchydectomy].
Mottet N; Rousmans S; Culine S
Bull Cancer; 2008 Feb; 95(2):205-34. PubMed ID: 18330045
[TBL] [Abstract][Full Text] [Related]
26. Testicular self-examination and testicular cancer: a cost-utility analysis.
Aberger M; Wilson B; Holzbeierlein JM; Griebling TL; Nangia AK
Cancer Med; 2014 Dec; 3(6):1629-34. PubMed ID: 25103095
[TBL] [Abstract][Full Text] [Related]
27. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
[TBL] [Abstract][Full Text] [Related]
28. Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.
Lewin J; Soltan Ghoraie L; Bedard PL; Hamilton RJ; Chung P; Moore M; Jewett MAS; Anson-Cartwright L; Virtanen C; Winegarden N; Tsao J; Warde P; Sweet J; Haibe-Kains B; Hansen AR
BJU Int; 2018 Nov; 122(5):814-822. PubMed ID: 29726090
[TBL] [Abstract][Full Text] [Related]
29. Reply to L.C. Pagliaro et al.
Kollmannsberger CK; Nichols CR
J Clin Oncol; 2015 Jul; 33(20):2328. PubMed ID: 26033817
[No Abstract] [Full Text] [Related]
30. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
31. Surveillance in testicular cancer: who, when, what and how?
Sohaib SA; Husband J
Cancer Imaging; 2007 Oct; 7(1):145-7. PubMed ID: 17964956
[TBL] [Abstract][Full Text] [Related]
32. Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review.
Ruf CG; Schmidt S; Kliesch S; Oing C; Pfister D; Busch J; Heinzelbecker J; Winter C; Zengerling F; Albers P; Oechsle K; Krege S; Lackner J; Dieckmann KP
World J Urol; 2022 Dec; 40(12):2889-2900. PubMed ID: 36107211
[TBL] [Abstract][Full Text] [Related]
33. Reply to L.C. Pagliaro et al.
Feldman DR
J Clin Oncol; 2015 Jul; 33(20):2327-8. PubMed ID: 26033811
[No Abstract] [Full Text] [Related]
34. [A clinical study of testicular tumors].
Matsuki H; Ozono S; Arai K; Saka M; Cho M; Nakagawa Y; Kaneko Y; Yoshida K; Okamoto S; Maruyama Y
Hinyokika Kiyo; 1988 Oct; 34(10):1757-65. PubMed ID: 2854363
[TBL] [Abstract][Full Text] [Related]
35. Evolving patterns of care in the management of stage I non-seminomatous germ cell tumors: data from the California Cancer Registry.
Yap SA; Yuh LM; Evans CP; Dall'Era MA; Wagenaar RM; Cress R; Lara PN
World J Urol; 2017 Feb; 35(2):277-283. PubMed ID: 27306686
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
Warde P; Specht L; Horwich A; Oliver T; Panzarella T; Gospodarowicz M; von der Maase H
J Clin Oncol; 2002 Nov; 20(22):4448-52. PubMed ID: 12431967
[TBL] [Abstract][Full Text] [Related]
37. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
38. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
39. Assessment of Prognostic Factors of Racial Disparities in Testicular Germ Cell Tumor Survival in the United States (1992-2015).
Wu J; Ji YB; Tang BW; Brown M; Wang BH; Du CL; Du JS; Wang XM; Cai LJ; Wu GY; Zhou Y
Biomed Environ Sci; 2021 Feb; 34(2):152-162. PubMed ID: 33685574
[TBL] [Abstract][Full Text] [Related]
40. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
